139
Participants
Start Date
July 14, 2020
Primary Completion Date
February 12, 2024
Study Completion Date
October 15, 2024
Risankizumab
Subcutaneous Injection
Ustekinumab
Subcutaneous Injection
Duplicate_Forest Hills Dermatology Group /ID# 227941, Kew Gardens
Universitaetsklinikum Schleswig-Holstein Campus Kiel /ID# 226013, Kiel
West Virginia University Hospitals /ID# 228352, Morgantown
Hospital General Universitario Gregorio Maranon /ID# 225721, Madrid
Hospital Universitario Infanta Leonor /ID# 225720, Madrid
Hospital Universitario 12 de Octubre /ID# 227860, Madrid
Medical University of South Carolina /ID# 217735, Charleston
Solutions Through Adv Rch /ID# 217936, Jacksonville
Advanced Clinical Research Institute /ID# 222706, Tampa
UAB Department of Dermatology /ID# 218834, Birmingham
Complejo Hospitalario Universitario de Pontevedra /ID# 226061, Pontevedra
The Ohio State University /ID# 217808, Columbus
Univ Hosp Cleveland /ID# 228483, Cleveland
Apex Clinical Research Center /ID# 228537, Mayfield Heights
Universitaetsklinikum Muenster /ID# 225988, Münster
Fachklinik Bad Bentheim /ID# 226014, Bad Bentheim
Universitaetsklinikum Bonn /ID# 228880, Bonn
Wisconsin Medical Center /ID# 240005, Milwaukee
Duplicate_Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz /ID# 225987, Mainz
Duplicate_Arlington Dermatology /ID# 217472, Rolling Meadows
University Dermatology and Vein Clinic, LLC /ID# 222778, Darien
Arlington Research Center, Inc /ID# 217471, Arlington
Duplicate_Skin Cancer and Dermatology Institute (SCDI) /ID# 221738, Reno
University of California San Diego - Rady Children's Hospital San Diego /ID# 217906, San Diego
First OC Dermatology /ID# 217733, Fountain Valley
Integrative Skin Science and Research /ID# 221741, Sacramento
Rybear, Inc /ID# 223164, Fort Lauderdale
Olympian Clinical Research- St. Petersburg /ID# 217941, St. Petersburg
Vital Prospects Clinical Research Institute, PC /ID# 217960, Tulsa
Clinical Investigation Specialist, Inc - Kenosha /ID# 223161, Kenosha
Duplicate_Dermatology Research Institute Inc. /ID# 226172, Calgary
Karma Clinical Trials /ID# 226177, St. John's
Hospital for Sick Children /ID# 226167, Toronto
CHU Sainte-Justine /ID# 226170, Montreal
Universitaetsklinikum Carl Gustav Carus Dresden /ID# 228881, Dresden
Nagoya City University Hospital /ID# 230830, Nagoya
Hiroshima University Hospital /ID# 256162, Hiroshima
Mie University Hospital /ID# 230836, Tsu
Kansai Medical University Hospital /ID# 231215, Hirakata-shi
Duplicate_Teikyo University Hospital /ID# 255188, Itabashi-ku
Tokyo Medical University Hospital /ID# 230575, Shinjuku-ku
High-Med Przychodnia Specjalistyczna /ID# 226060, Warsaw
Uniwersytecki Szpital Kliniczny im. F. Chopina w Rzeszowie /ID# 226116, Rzeszów
Centrum Badan Klinicznych PI-House sp. z o.o. /ID# 228252, Gdansk
Dermed Centrum Medyczne Sp. z o.o /ID# 226062, Lodz
Dermoklinika Centrum Medyczne s.c. /ID# 226063, Lodz
Hospital Sant Joan de Deu /ID# 225722, Esplugues de Llobregat
Duplicate_Royal Devon University Healthcare NHS Foundation Trust /ID# 228078, Exeter
Duplicate_University Hospital Plymouth NHS Trust /ID# 227230, Plymouth
Guys and St Thomas NHS Foundation Trust /ID# 227224, London
Chelsea and Westminster Hospital /ID# 227231, London
NHS Greater Glasgow and Clyde /ID# 227226, Glasgow
Frimley Health NHS Foundation Trust /ID# 229525, Camberley
Lead Sponsor
AbbVie
INDUSTRY